About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:6719029
Allelic
Composition
Bcap31tm1.1Bwang/Bcap31tm1.1Bwang
Tg(Lck-cre)548Jxm/0
Genetic
Background
involves: C57BL/6 * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Bcap31tm1.1Bwang mutation (0 available); any Bcap31 mutation (8 available)
Tg(Lck-cre)548Jxm mutation (2 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• accelerated apoptosis in freshly isolated thymocytes after tunicamycin treatment
• decreased thymus size in young adult (3-, 5- or 8-week-old) and older mice (6-month-old)
• decreased thymus weight in young adult and older mice
• reduced total thymocyte number in young adult and older mice
• however, development of double-negative (DN) thymocytes and CD4+ and CD8+ single-positive (SP) thymocytes is normal
• no significant change in DN1-4 thymic subsets
• decreased % of naive (CD44lowCD62Lhi) in CD4+ and CD8+ T cells in the spleen and lymph nodes of young adult (8-wk-old) and older mice (6-mo-old)
• increased % of effector/memory T cells (CD44hiCD62Llo) in CD4+ and CD8+ T cells in the spleen and lymph nodes of young adult (8-wk-old) and older mice (6-mo-old)
• decreased percentage of CD4+ and CD8+ single positive (SP) mature T lymphocytes in the spleen and lymph nodes of young adult (3-, 5- or 8-week-old) and older mice (6-month-old)
• decreased percentage of CD4+ and CD8+ T cells in peripheral blood
• however, expression of class I MHC molecules on CD4+ and CD8+ SP splenocytes is normal
• marked reduction in IL-2 and IFN-gamma production following stimulation of total splenocytes with anti-CD3 plus anti-CD28
• reduced T cell proliferation following stimulation of total splenocytes with anti-CD3 plus anti-CD28
• marked reduction in IFN-gamma production following stimulation of total splenocytes with anti-CD3 plus anti-CD28; also detected at the mRNA level
• marked reduction in IL-2 production following stimulation of total splenocytes with anti-CD3 plus anti-CD28; also detected at the mRNA level

hematopoietic system
• accelerated apoptosis in freshly isolated thymocytes after tunicamycin treatment
• decreased thymus size in young adult (3-, 5- or 8-week-old) and older mice (6-month-old)
• decreased thymus weight in young adult and older mice
• reduced total thymocyte number in young adult and older mice
• however, development of double-negative (DN) thymocytes and CD4+ and CD8+ single-positive (SP) thymocytes is normal
• no significant change in DN1-4 thymic subsets
• decreased % of naive (CD44lowCD62Lhi) in CD4+ and CD8+ T cells in the spleen and lymph nodes of young adult (8-wk-old) and older mice (6-mo-old)
• increased % of effector/memory T cells (CD44hiCD62Llo) in CD4+ and CD8+ T cells in the spleen and lymph nodes of young adult (8-wk-old) and older mice (6-mo-old)
• decreased percentage of CD4+ and CD8+ single positive (SP) mature T lymphocytes in the spleen and lymph nodes of young adult (3-, 5- or 8-week-old) and older mice (6-month-old)
• decreased percentage of CD4+ and CD8+ T cells in peripheral blood
• however, expression of class I MHC molecules on CD4+ and CD8+ SP splenocytes is normal
• marked reduction in IL-2 and IFN-gamma production following stimulation of total splenocytes with anti-CD3 plus anti-CD28
• reduced T cell proliferation following stimulation of total splenocytes with anti-CD3 plus anti-CD28

cellular
• accelerated apoptosis in freshly isolated thymocytes after tunicamycin treatment
• reduced T cell proliferation following stimulation of total splenocytes with anti-CD3 plus anti-CD28

endocrine/exocrine glands
• accelerated apoptosis in freshly isolated thymocytes after tunicamycin treatment
• decreased thymus size in young adult (3-, 5- or 8-week-old) and older mice (6-month-old)
• decreased thymus weight in young adult and older mice
• reduced total thymocyte number in young adult and older mice
• however, development of double-negative (DN) thymocytes and CD4+ and CD8+ single-positive (SP) thymocytes is normal
• no significant change in DN1-4 thymic subsets


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
01/28/2026
MGI 6.24
The Jackson Laboratory